Washed human platelets were stimulated with fibrillar collagen and platelet aggregation was prevented by non-stirring conditions. In these samples, electron microscopy revealed three fractions of platelets: 1) a majority without contacts to the collagen fibers, 2) with focal contacts to collagen, and 3) a small fraction of platelets with internalized collagen. All platelets had undergone shape change, and exhibited an internal contraction and granule release. However, only those with internalized collagen were completely degranulated. The internalized collagen was found to be in close contact to the contractile sphere in the platelet center, as it was demonstrable with computer assisted 3-D reconstruction from serial sections. Aspirin inhibited neither the adhesion to collagen nor its internalization by internal contraction. Also it did not impair the shape change and degranulation in the platelet fractions that internalized collagen. However, aspirin blocked the shape change and internal contraction of the other platelets and inhibited the [3H]serotonin release. Cytochalasin D 0.1 uM also suppressed the internalization of collagen, the shape change, the formation of a contractile gel, the degranulation, and the [3H]serotonin release in all platelets, whereas the number of platelets that adhered to collagen remained unchanged. The same effects were produced by prostaglandin E1. If the platelets were stimulated with the TXA2 mimetic, U46619, cytochalasin D at 0.1 εM had no effect; but at 20 εM it strongly enhanced the degranulation and the [3H]serotonin release, although the platelets remained discoid. It is concluded that collagen triggers a focal activation of an adherent platelet at the site of its initial contact to collagen. This subthreshold activation proceeds to degranulation and TXA2 formation via a feedback cascade which involves internal contraction, internalization of collagen and multiplication of the collagen membrane contacts.
References
1
Nossel HL,
Wilner GD,
LeRoy EC.
Aggregation of platelets by collagen. J Clin Invest 1968; 47: 2616-21
3
Sano K,
Takai Y,
Yamanishi J,
Nishizuka Y.
A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. J Biol Chem 1983; 258: 2010-3
4
Siess W,
Cuatrecasas P,
Lapetina EG.
A role for cyclooxygenase products in the formation of phosphatidic acid in stimulated human platelets. Differential mechanisms of action of thrombin and collagen. J Biol Chem 1983; 258: 4683-6
10
Patscheke H,
Stegmaier K.
Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Thromb Res 1984; 33: 277-88
11
Ruf A,
Morgenstern E,
Janzarik H,
Lüscher EF.
Morphology of the interaction of collagen fibrils with normal human platelets and thrombastenic platelets. Thromb Res 1986; 44: 477-87
12
Jelenska MM,
Kopec M.
Platelet-mediated collagen and fibrin retraction: Effect of prostaglandins, cyclic AMP, calcium antagonists and n-ethylmaleimide. Thromb Res 1983; 30: 499-509
18
Flanagan MD,
Lin S.
Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem 1980; 255: 835-8
20
Feinstein MB,
Egan JJ,
Sha'afi RI,
White J.
The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2), PGE1, forskolin. Biochem Biophys Res Commun 1983; 113: 598-604
21
Imai A,
Hattori H,
Takahashi M,
Nozawa Y.
Evidence that cyclic AMP may regulate Ca2+-mobilization and phospholipases in thrombin-stimulated human platelets. Biochem Biophys Res Commun 1983; 112: 693-700
28
Morgenstern E,
Neumann K,
Patscheke H.
The exocytosis of human blood platelets. A fast freeze-substitution analysis. Eur J Cell Biol 1987; 43: 273-82
29
Morgenstern E,
Patscheke H,
Mathieu G.
The origin of the membrane convolute in degranulating platelets. A comparative study of normal and "gray" platelets. Blut 1990; 60: 15-22
31
Leytin VL,
Misselwitz F,
Lyubimova EV,
Domogatsky SP.
The role of platelet prostanoids and dense granule compounds in initial attachment, spreading and aggregation of platelets on collagen substrates. Thromb Res 1989; 55: 395-406
33
Lapetina EG,
Reep B,
Read NG,
Moncada S.
Adhesion of platelets to collagen in the presence of prostacyclin, indomethacin, and compound BW755C. Thromb Res 1986; 37: 325-31
34
Misselwitz F,
Leytin VL,
Repin VS.
Role of signal transduction systems in the interaction of platelet with collagen. Biomed Biochim Acta 1987; 46: 759-62
36
Feinstein MB.
Release of intracellular membrane-bound calcium precedes the onset of stimulus-induced exocytosis in platelets. Biochem Biophys Res Commun 1980; 93: 593-600
37
Fox JEB,
Say AK,
Haslam RJ.
Subcellular distribution of the different platelet proteins phosphorylated on exposure of intact platelets to ionophore A 23187 or to prostaglandin E1. Possible role of membrane phosphopolypeptide in the regulation of calcium-ion transport. Biochem J 1979; 184: 651-61
38
Fox JEB,
Phillips DR.
Role of phosphorylation in mediating the association of myosin with the cytoskeletal structures of human platelets. J Biol Chem 1982; 257: 4120-6
41
Staatz WD,
Rajpara SM,
Wayner EA,
Carter WG,
Santoro SA.
The membrane Glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of the platelets to collagen. J Cell Biol 1989; 108: 1917-24
42
Fox JEB.
Identification of actin-binding protein as the protein linking the membrane skeleton to glycoproteins on platelet plasma membranes. J Biol Chem 1985; a 11970-7
43
Nakano T,
Hanasaki K,
Arita H.
Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets. J Biol Chem 1989; 264: 5400-6
44
Peerschke I,
Zucker MB.
Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B. Thromb Haemostas 1980; 43: 58-60
47
Misselwitz F,
Domogatzky SP,
Repin VS,
Spangenberg P,
Till U.
Substances that polymerize or depolymerize cytoskeletal proteins affect platelet spreading and thrombus-formation on surfaces coated with human collagen isotypes I, IV and V. Thromb Res 1988; 50: 627-36